Related Experiment Video
Updated: Aug 15, 2026

16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
KDI tripeptide from laminin: a novel approach to treat neurodegenerative disorders
Drug Discovery Today
|October 11, 2005
Abstract:
The excessive release of glutamate following brain injury is responsible for the phenomenon of glutamate excitotoxicity, mediated through glutamate receptors, resulting in apoptotic cell death. KDI ameliorates excitotoxicity and regenerates damaged nerve cells.